Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

NextCell Pharma AB

Closing information (x1000 EUR)

Closing information 2024/08 2023/08 2022/08
Turnover 941 Less Arrow 854 Less Arrow 523
Financial expenses 0 Equal arrow 0 More Arrow 1
Earnings before taxes -3,702 More Arrow -3,362 More Arrow -3,235
EBITDA -3,723 More Arrow -3,424 More Arrow -3,236
Total assets 7,171 More Arrow 7,500 More Arrow 11,669
Current assets 5,348 More Arrow 5,680 More Arrow 9,994
Current liabilities 871 Less Arrow 851 Less Arrow 649
Equity capital 5,963 More Arrow 6,394 More Arrow 10,816
- share capital 1,322 Less Arrow 595 More Arrow 660
Employees (average) 24 Less Arrow 17 Less Arrow 15

Financial ratios

Fiscal year 2024/08 2023/08 2022/08
Solvency 83.2% More Arrow 85.3% More Arrow 92.7%
Turnover per employee 39 More Arrow 50 Less Arrow 35
Profit as a percentage of turnover -393.4% Less Arrow -393.7% Less Arrow -618.5%
Return on assets (ROA) -51.6% More Arrow -44.8% More Arrow -27.7%
Current ratio 614.0% More Arrow 667.5% More Arrow 1539.9%
Return on equity (ROE) -62.1% More Arrow -52.6% More Arrow -29.9%
Change turnover 49 More Arrow 382 Less Arrow 157
Change turnover % 5% More Arrow 81% Less Arrow 43%
Chg. No. of employees 7 Less Arrow 2 Equal arrow 2
Chg. No. of employees % 41% Less Arrow 13% More Arrow 15%

Total value of public sale

Fiscal year 2024/08 2023/08 2022/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.